Hims & Hers Health Inc. (NYSE: HIMS) is 55.23% higher on its value in year-to-date trading and has touched a low of $2.72 and a high of $12.04 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The HIMS stock was last observed hovering at around $9.01 in the last trading session, with the day’s gains setting it 0.94%.
Currently trading at $9.95, the stock is 1.90% and 16.79% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.88 million and changing 10.43% at the moment leaves the stock 57.02% off its SMA200. HIMS registered 129.26% gain for a year compared to 6-month gain of 62.05%.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
The stock witnessed a 1.02% loss in the last 1 month and extending the period to 3 months gives it a 35.37%, and is 4.30% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.54% over the week and 6.29% over the month.
Hims & Hers Health Inc. (HIMS) has around 651 employees, a market worth around $2.21B and $526.90M in sales. Profit margin for the company is -12.50%. Distance from 52-week low is 265.81% and -17.37% from its 52-week high. The company has generated returns on investments over the last 12 months (-22.00%).
Hims & Hers Health Inc. (HIMS) Analyst Forecasts
Hims & Hers Health Inc. is expected to release its quarterly report on 05/15/2023.The EPS is expected to grow by 44.30% this year
Hims & Hers Health Inc. (HIMS) Top Institutional Holders
The shares outstanding are 206.16M, and float is at 155.83M with Short Float at 12.23%.
Hims & Hers Health Inc. (HIMS) Insider Activity
A total of 40 insider transactions have happened at Hims & Hers Health Inc. (HIMS) in the last six months, with sales accounting for 22 and purchases happening 18 times. The most recent transaction is an insider sale by Boughton Soleil, the company’s Chief Legal Officer. SEC filings show that Boughton Soleil sold 2,000 shares of the company’s common stock on Mar 14 at a price of $9.09 per share for a total of $18180.0. Following the sale, the insider now owns 0.17 million shares.
Hims & Hers Health Inc. disclosed in a document filed with the SEC on Mar 08 that WELLS DAVID B (Director) sold a total of 100,000 shares of the company’s common stock. The trade occurred on Mar 08 and was made at $9.77 per share for $0.98 million. Following the transaction, the insider now directly holds 0.34 million shares of the HIMS stock.
Still, SEC filings show that on Mar 03, Dudum Andrew (Chief Executive Officer) disposed off 1,249 shares at an average price of $11.96 for $14933.0. The insider now directly holds 350,615 shares of Hims & Hers Health Inc. (HIMS).